tradingkey.logo

Cooper Companies Inc

COO
82.750USD
+0.290+0.35%
Fechamento 12/19, 16:00ETCotações atrasadas em 15 min
16.21BValor de mercado
43.95P/L TTM

Cooper Companies Inc

82.750
+0.290+0.35%

Mais detalhes de Cooper Companies Inc Empresa

The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.

Informações de Cooper Companies Inc

Código da empresaCOO
Nome da EmpresaCooper Companies Inc
Data de listagemJan 21, 1983
CEOWhite (Albert G)
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalJan 21
Endereço6101 Bollinger Canyon Road
CidadeSAN RAMON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94583
Telefone19254603600
Sitehttps://www.coopercos.com/
Código da empresaCOO
Data de listagemJan 21, 1983
CEOWhite (Albert G)

Executivos da empresa Cooper Companies Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Director
Director
554.31K
+0.54%
Mr. Daniel G. (Dan) Mcbride, Esq.
Mr. Daniel G. (Dan) Mcbride, Esq.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
157.62K
+1.94%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
37.82K
+32.55%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Chairman of the Board
Independent Chairman of the Board
29.52K
+10.15%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
12.01K
+29.30%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
10.14K
+36.67%
Ms. Cynthia L. (Cindy) Lucchese, CPA
Ms. Cynthia L. (Cindy) Lucchese, CPA
Independent Director
Independent Director
7.66K
+55.08%
Mr. Agostino Ricupati
Mr. Agostino Ricupati
Senior Vice President - Finance and Tax, Chief Accounting Officer
Senior Vice President - Finance and Tax, Chief Accounting Officer
7.51K
+15.72%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Director
Independent Director
5.78K
+52.95%
Mr. Nicholas S. Khadder, J.D.
Mr. Nicholas S. Khadder, J.D.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
2.14K
+320.67%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Director
Director
554.31K
+0.54%
Mr. Daniel G. (Dan) Mcbride, Esq.
Mr. Daniel G. (Dan) Mcbride, Esq.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
157.62K
+1.94%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
37.82K
+32.55%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Chairman of the Board
Independent Chairman of the Board
29.52K
+10.15%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
12.01K
+29.30%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
10.14K
+36.67%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Sphere, other
359.60M
33.91%
Toric and multifocal
358.80M
33.84%
Office and surgical procedures
204.80M
19.32%
Fertility
137.10M
12.93%
Por RegiãoUSD
Nome
Receita
Proporção
United States
516.20M
48.68%
Europe
343.10M
32.36%
Rest of the World
201.00M
18.96%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Sphere, other
359.60M
33.91%
Toric and multifocal
358.80M
33.84%
Office and surgical procedures
204.80M
19.32%
Fertility
137.10M
12.93%

Distribuição de ações

Atualizado em: seg, 17 de nov
Atualizado em: seg, 17 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
12.19%
Capital World Investors
5.38%
BlackRock Institutional Trust Company, N.A.
5.02%
T. Rowe Price Investment Management, Inc.
5.01%
State Street Investment Management (US)
4.38%
Outro
68.01%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
12.19%
Capital World Investors
5.38%
BlackRock Institutional Trust Company, N.A.
5.02%
T. Rowe Price Investment Management, Inc.
5.01%
State Street Investment Management (US)
4.38%
Outro
68.01%
Tipos de investidores
Investidores
Proporção
Investment Advisor
58.31%
Investment Advisor/Hedge Fund
34.98%
Hedge Fund
6.21%
Research Firm
3.96%
Bank and Trust
1.29%
Pension Fund
1.27%
Family Office
0.91%
Family Office
0.91%
Family Office
0.70%

Participação acionária institucional

Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
1362
208.96M
111.56%
-3.88K
2025Q3
1410
208.99M
111.74%
+4.12M
2025Q2
1399
205.52M
107.52%
+1.81M
2025Q1
1380
203.24M
103.36%
-3.45M
2024Q4
1357
199.65M
102.09%
+3.47M
2024Q3
1324
195.11M
102.83%
-1.38M
2024Q2
1308
196.62M
100.46%
+4.01M
2024Q1
1307
191.91M
103.85%
-14.49M
2023Q4
1291
198.78M
104.05%
+1.21M
2023Q3
1279
197.30M
102.69%
+609.87K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
24.16M
12.15%
+419.27K
+1.77%
Jun 30, 2025
Capital World Investors
8.39M
4.22%
+645.79K
+8.34%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.76M
4.91%
-120.78K
-1.22%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
7.38M
3.71%
+106.52K
+1.46%
Jun 30, 2025
State Street Investment Management (US)
8.66M
4.36%
+104.91K
+1.23%
Jun 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
7.85M
3.95%
-130.44K
-1.63%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.21M
2.62%
+127.91K
+2.52%
Jun 30, 2025
Sustainable Growth Advisers, LP
3.39M
1.7%
+2.79M
+466.43%
Jun 30, 2025
Neuberger Berman, LLC
5.06M
2.55%
+1.46M
+40.32%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
First Trust Indxx Medical Devices ETF
2.05%
Themes US R&D Champions ETF
1.96%
Invesco Bloomberg Pricing Power ETF
1.89%
State Street SPDR S&P Health Care Equipment ETF
1.85%
Invesco S&P 500 Equal Weight Health Care ETF
1.69%
Motley Fool Mid-Cap Growth ETF
1.59%
Congress SMid Growth ETF
1.42%
Invesco ESG NASDAQ Next Gen 100 ETF
1.19%
Pacer US Export Leaders ETF
0.95%
First Trust Health Care Alphadex Fund
0.89%
Ver Mais
First Trust Indxx Medical Devices ETF
Proporção2.05%
Themes US R&D Champions ETF
Proporção1.96%
Invesco Bloomberg Pricing Power ETF
Proporção1.89%
State Street SPDR S&P Health Care Equipment ETF
Proporção1.85%
Invesco S&P 500 Equal Weight Health Care ETF
Proporção1.69%
Motley Fool Mid-Cap Growth ETF
Proporção1.59%
Congress SMid Growth ETF
Proporção1.42%
Invesco ESG NASDAQ Next Gen 100 ETF
Proporção1.19%
Pacer US Export Leaders ETF
Proporção0.95%
First Trust Health Care Alphadex Fund
Proporção0.89%

Dividendo

Um total de 9.00M USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Jul 12, 2023
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2023 going ex on Jul 26, 2023
Jul 27, 2023
Aug 11, 2023
Jul 26, 2023
Dec 14, 2022
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2023 going ex on Jan 20, 2023
Jan 23, 2023
Feb 10, 2023
Jan 20, 2023
Jul 13, 2022
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2022 going ex on Jul 26, 2022
Jul 27, 2022
Aug 11, 2022
Jul 26, 2022
Dec 08, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2022 going ex on Jan 20, 2022
Jan 21, 2022
Feb 09, 2022
Jan 20, 2022
Jul 14, 2021
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2021 going ex on Jul 26, 2021
Jul 27, 2021
Aug 11, 2021
Jul 26, 2021
Jan 07, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2021 going ex on Jan 21, 2021
Jan 22, 2021
Feb 09, 2021
Jan 21, 2021
Jul 09, 2020
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 07, 2020 going ex on Jul 22, 2020
Jul 23, 2020
Aug 07, 2020
Jul 22, 2020
Jan 07, 2020
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2020 going ex on Jan 22, 2020
Jan 23, 2020
Feb 10, 2020
Jan 22, 2020

Desdobramento de ações

Data
Tipo
Proporção
Dec 07, 2023
Split
1→4
Data
Tipo
Proporção
Dec 07, 2023
Split
1→4

Perguntas frequentes

Quem são os cinco principais acionistas de Cooper Companies Inc?

Os cinco principais acionistas de Cooper Companies Inc são:
The Vanguard Group, Inc. detém 24.16M Ações, representando 12.15% do total de Ações.
Capital World Investors detém 8.39M Ações, representando 4.22% do total de Ações.
BlackRock Institutional Trust Company, N.A. detém 9.76M Ações, representando 4.91% do total de Ações.
T. Rowe Price Investment Management, Inc. detém 7.38M Ações, representando 3.71% do total de Ações.
State Street Investment Management (US) detém 8.66M Ações, representando 4.36% do total de Ações.

Quais são os três principais tipos de acionistas de Cooper Companies Inc?

Os três principais tipos de acionistas da Cooper Companies Inc são:
The Vanguard Group, Inc.
Capital World Investors
BlackRock Institutional Trust Company, N.A.

Quantas instituições possuem ações da Cooper Companies Inc (COO)?

Em 2025Q4, 1362 instituições possuíam ações da Cooper Companies Inc, com valor de mercado aproximado de 208.96M, representando 111.56% do total de ações. Em comparação com 2025Q3, a participação institucional aumentou em -0.18%.

Qual é a maior fonte de receita da Cooper Companies Inc?

Em FY2025Q3, o segmento de negócios Sphere, other gerou a maior receita para Cooper Companies Inc, totalizando 359.60M e representando 33.91% da receita total.
KeyAI